775 related articles for article (PubMed ID: 26076826)
1. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
[TBL] [Abstract][Full Text] [Related]
2. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
4. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity.
Su CC; Shau WY; Wang CR; Chuang CY; Chen CY
Lupus; 1997; 6(5):449-54. PubMed ID: 9229364
[TBL] [Abstract][Full Text] [Related]
5. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
6. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia.
Amasaki Y; Kobayashi S; Takeda T; Ogura N; Jodo S; Nakabayashi T; Tsutsumi A; Fujisaku A; Koike T
Clin Exp Immunol; 1995 Feb; 99(2):245-50. PubMed ID: 7531628
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
[TBL] [Abstract][Full Text] [Related]
9. T cell subsets and immunoglobulin G levels are associated with the infection status of systemic lupus erythematosus patients.
Wu L; Wang X; Chen F; Lv X; Sun W; Guo Y; Hou H; Ji H; Wei W; Gong L
Braz J Med Biol Res; 2017 Dec; 51(2):e4547. PubMed ID: 29267496
[TBL] [Abstract][Full Text] [Related]
10. High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid Arthritis.
Song L; Wang Y; Sui Y; Sun J; Li D; Li G; Liu J; Li T; Shu Q
Med Sci Monit; 2018 Aug; 24():5660-5667. PubMed ID: 30106887
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of human T-cell immunoglobulin- and mucin-domain-containing molecule-4 in peripheral blood mononuclear cells from patients with system lupus erythematosus.
Zhao P; Xu L; Wang P; Liang X; Qi J; Liu P; Guo C; Zhang L; Ma C; Gao L
Cell Mol Immunol; 2010 Mar; 7(2):152-6. PubMed ID: 20140011
[TBL] [Abstract][Full Text] [Related]
12. Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients.
Wang Y; Meng J; Wang X; Liu S; Shu Q; Gao L; Ju Y; Zhang L; Sun W; Ma C
Scand J Immunol; 2008 Jan; 67(1):63-70. PubMed ID: 18052965
[TBL] [Abstract][Full Text] [Related]
13. CD3
Mohd Shukri ND; Farah Izati A; Wan Ghazali WS; Che Hussin CM; Wong KK
Front Immunol; 2021; 12():675250. PubMed ID: 34149710
[TBL] [Abstract][Full Text] [Related]
14. [Role of Fas-FasL and caspase-3 signal transduction pathway in promoting apoptosis of T lymphocyte subset in SLE patients].
Chen X; Wang LL; Cai B; Chen J; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):588-90. PubMed ID: 16948902
[TBL] [Abstract][Full Text] [Related]
15. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
Feng Y
Hokkaido Igaku Zasshi; 1997 Jul; 72(4):443-55. PubMed ID: 9266252
[TBL] [Abstract][Full Text] [Related]
16. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
17. Decreased serum levels of T-cell immunoglobulin mucin-1 and T-cell immunoglobulin mucin-3 in systemic lupus erythematosus patients.
Yuan H; Yao YS; Chen GM; Sheng J; Xu L; Pan HF
J Biol Regul Homeost Agents; 2016; 30(1):123-9. PubMed ID: 27049082
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
19. Association of Serum T cell Immunoglobulin Domain and Mucin-3 and Interleukin-17 with Systemic Lupus Erythematosus.
Jin L; Bai R; Zhou J; Shi W; Xu L; Sheng J; Peng H; Jin Y; Yuan H
Med Sci Monit Basic Res; 2018 Oct; 24():168-176. PubMed ID: 30348938
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
